[HTML][HTML] Locked nucleic acid: modality, diversity, and drug discovery

PH Hagedorn, R Persson, ED Funder, N Albæk… - Drug Discovery …, 2018 - Elsevier
Highlights•Locked nucleic acid-modified antisense oligonucleotides (LNAs) bind to and
modulate RNA.•The high binding affinity of LNAs significantly improves potency.•Structural …

Locked vs. unlocked nucleic acids (LNA vs. UNA): contrasting structures work towards common therapeutic goals

MA Campbell, J Wengel - Chemical Society Reviews, 2011 - pubs.rsc.org
Oligonucleotide chemistry has been developed greatly over the past three decades, with
many advances in increasing nuclease resistance, enhancing duplex stability and assisting …

[BOK][B] Chemical synthesis of nucleoside analogues

P Merino - 2013 - Wiley Online Library
Nucleosides are the building blocks required in constructing nucleic acids. As we learned in
school, billions of combinations are possible using only four different nucleosides, and thus …

DNA Mimics for the Rapid Identification of Microorganisms by Fluorescence in situ Hybridization (FISH)

L Cerqueira, NF Azevedo, C Almeida, T Jardim… - International Journal of …, 2008 - mdpi.com
Fluorescence in situ hybridization (FISH) is a well-established technique that is used for a
variety of purposes, ranging from pathogen detection in clinical diagnostics to the …

Oligomeric compounds for the modulation of Bcl-2

M Frieden, JB Hansen, H Orum, M Westergaard… - US Patent …, 2009 - Google Patents
The present invention provides improved oligomeric com pound, in particular
oligonucleotide compounds, and meth ods for modulating the expression of the Bcl-2 gene …

MicroRNAs

S Obad, S Kauppinen, J Elmen, M Lindow… - US Patent …, 2012 - Google Patents
First worldwide family litigation filed litigation Critical https://patents. darts-ip. com/? family=
40526747&utm_source= google_patent&utm_medium= platform_link&utm_campaign …

Beyond ribose and phosphate: selected nucleic acid modifications for structure–function investigations and therapeutic applications

C Liczner, K Duke, G Juneau, M Egli… - Beilstein Journal of …, 2021 - beilstein-journals.org
Over the past 25 years, the acceleration of achievements in the development of
oligonucleotide-based therapeutics has resulted in numerous new drugs making it to the …

Pharmaceutical compositions for treatment of microRNA related diseases

S Kauppinen, N Abrahamsen… - US Patent …, 2013 - Google Patents
The present invention provides compositions and methods of treatment of diseases that are
sensitive to drugs that downregulate the function of microRNA's, mRNA, non-coding RNA, or …

Scaffolding along nucleic acid duplexes using 2′-amino-locked nucleic acids

IK Astakhova, J Wengel - Accounts of chemical research, 2014 - ACS Publications
Conspectus Incorporation of chemically modified nucleotide scaffolds into nucleic acids to
form assemblies rich in function is an innovative area with great promise for nanotechnology …

On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti‐H‐Ras antisense oligonucleotide

K Fluiter, M Frieden, J Vreijling, C Rosenbohm… - …, 2005 - Wiley Online Library
Locked nucleic acid (β‐d‐LNA) monomers are conformationally restricted nucleotides
bearing a methylene 2′‐O, 4′‐C linkage that have an unprecedented high affinity for …